Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MICHELLE FUENTES LOMOTAN

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1265952717
CMS profile
7264756
Location
EDISON, NJ

General Payments · PY2020–2024

$2,621.90

  • Reported across 186 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$643.42

39 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2020 $182.87 13
PY2021 $791.40 61
PY2022 $512.99 41
PY2023 $491.22 32
PY2024 $643.42 39

Payment records · PY2024 (39)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $23.96 03/13/2024 Food and Beverage Undisputed 01/23/2026 1124941587 CMS
AstraZeneca Pharmaceuticals LP $14.01 01/04/2024 Food and Beverage Undisputed 01/23/2026 1104433915 CMS
AstraZeneca Pharmaceuticals LP $16.12 06/26/2024 Food and Beverage Undisputed 01/23/2026 1105366533 CMS
AstraZeneca Pharmaceuticals LP $16.09 07/02/2024 Food and Beverage Undisputed 01/23/2026 1105448815 CMS
AstraZeneca Pharmaceuticals LP $13.15 08/19/2024 Food and Beverage Undisputed 01/23/2026 1104203189 CMS
AstraZeneca Pharmaceuticals LP $17.70 09/24/2024 Food and Beverage Undisputed 01/23/2026 1105882723 CMS
AstraZeneca Pharmaceuticals LP $14.38 10/28/2024 Food and Beverage Undisputed 01/23/2026 1105563116 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $16.45 04/01/2024 Food and Beverage Undisputed 01/23/2026 1117941997 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $17.03 06/18/2024 Food and Beverage Undisputed 01/23/2026 1117941999 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $15.28 10/22/2024 Food and Beverage Undisputed 01/23/2026 1117941995 CMS
Currax Pharmaceuticals LLC $15.17 04/29/2024 Food and Beverage Undisputed 01/23/2026 1089513532 CMS
Currax Pharmaceuticals LLC $14.96 10/21/2024 Food and Beverage Undisputed 01/23/2026 1089513534 CMS
Dynavax Technologies Corporation $17.31 01/29/2024 Food and Beverage Undisputed 01/23/2026 1082144405 CMS
Dynavax Technologies Corporation $17.87 07/29/2024 Food and Beverage Undisputed 01/23/2026 1082149997 CMS
Esperion Therapeutics, Inc. $16.59 05/14/2024 Food and Beverage Undisputed 01/23/2026 1129444420 CMS
Exact Sciences Corporation $18.19 03/11/2024 Food and Beverage Undisputed 01/23/2026 1114456892 CMS
Lilly USA, LLC $16.62 02/07/2024 Food and Beverage Undisputed 01/23/2026 1135241160 CMS
Lilly USA, LLC $16.31 02/20/2024 Food and Beverage Undisputed 01/23/2026 1135230415 CMS
Lilly USA, LLC $18.31 04/17/2024 Food and Beverage Undisputed 01/23/2026 1135201987 CMS
Lilly USA, LLC $21.28 07/24/2024 Food and Beverage Undisputed 01/23/2026 1135204318 CMS
Medicure Pharma Inc. $29.18 04/09/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1089506574 CMS
Merck Sharp & Dohme LLC $16.95 04/30/2024 Food and Beverage Undisputed 01/23/2026 1141839937 CMS
Novo Nordisk Inc $17.24 02/12/2024 Food and Beverage Undisputed 01/23/2026 1097125989 CMS
Novo Nordisk Inc $11.37 02/26/2024 Food and Beverage Undisputed 01/23/2026 1097536463 CMS
Novo Nordisk Inc $13.41 03/28/2024 Food and Beverage Undisputed 01/23/2026 1097059659 CMS
Novo Nordisk Inc $13.86 04/15/2024 Food and Beverage Undisputed 01/23/2026 1096889092 CMS
Novo Nordisk Inc $12.92 05/10/2024 Food and Beverage Undisputed 01/23/2026 1097812584 CMS
Novo Nordisk Inc $16.43 06/24/2024 Food and Beverage Undisputed 01/23/2026 1096674278 CMS
Novo Nordisk Inc $12.56 06/25/2024 Food and Beverage Undisputed 01/23/2026 1097529307 CMS
Novo Nordisk Inc $7.58 07/24/2024 Food and Beverage Undisputed 01/23/2026 1097313643 CMS
Novo Nordisk Inc $16.75 08/06/2024 Food and Beverage Undisputed 01/23/2026 1097251045 CMS
Novo Nordisk Inc $12.28 09/11/2024 Food and Beverage Undisputed 01/23/2026 1097099194 CMS
Novo Nordisk Inc $9.60 09/25/2024 Food and Beverage Undisputed 01/23/2026 1097220469 CMS
Novo Nordisk Inc $21.05 09/26/2024 Food and Beverage Undisputed 01/23/2026 1097566579 CMS
Novo Nordisk Inc $16.81 10/09/2024 Food and Beverage Undisputed 01/23/2026 1097643892 CMS
Novo Nordisk Inc $21.05 10/11/2024 Food and Beverage Undisputed 01/23/2026 1097003562 CMS
Novo Nordisk Inc $23.79 10/29/2024 Food and Beverage Undisputed 01/23/2026 1096707947 CMS
Novo Nordisk Inc $17.77 11/22/2024 Food and Beverage Undisputed 01/23/2026 1097584622 CMS
Otsuka America Pharmaceutical, Inc. $16.04 01/30/2024 Food and Beverage Undisputed 01/23/2026 1118931786 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.